Iterative Health has raised $77 million in a Series C funding round to expand its AI-powered clinical research network.
The company focuses on improving clinical trial execution by embedding research directly into clinical care, using centralized operations, AI technology, and a global network of over 100 research sites. Its model has shown faster site activation and higher patient enrollment rates compared to industry benchmarks.
The new funding will support expansion beyond gastroenterology into areas like cardiology and obesity, as well as further geographic growth and partnerships with healthcare providers and research organizations.